Journal of Clinical Oncology (JCO) Podcast

starstarstarstarstar

The Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. Usually presented in conjunction with an original report and an editorial published on www.jco.org, the JCO podcasts enable readers to stay current on the latest research while placing the results into a clinically useful context.

RSS Feed URL

Claim this podcast

Remove this podcast

Play Latest Episode:

Title: Capecitabine Versus Continuous Infusion 5-FU for Rectal Cancer Neoadjuvant Chemoradiation: Equivalent Effectiveness Raises Real-World Questions About Efficacy, Adherence and Economic Implications

Capecitabine Versus Continuous Infusion 5-FU for Rectal Cancer Neoadjuvant Chemoradiation: Equivalent Effectiveness Raises Real-World Questions About Efficacy, Adherence and Economic Implications

May 5th, 2014

This trial supports the use of neoadjuvant capecitabine monotherapy as a potentially more convenient radiosensitizer that does not sacrifice surgical… Go to Episode

Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers

May 11th, 2015

This podcast places the results of SWOG S0809, a phase II intergroup trial of adjuvant capecitabine/gemcitabine followed by radiotherapy and concurrent… Go to Episode

A Second Chance at Checkpoint Inhibition After Initial Immune-Mediated Diarrhea and Colitis

June 6th, 2019

This JCO Podcast provides observations and commentary on the JCO article “Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated… Go to Episode

An Advance for the Treatment of Osteosarcoma

April 23rd, 2019

This podcast provides observations and commentary on the JCO article "Randomized, Double-Blind, Phase II Study of Regorafenib in Patients with Metastatic… Go to Episode